SCHEMBL7986725

SCHEMBL7986725

CC(=O)N([C@H](CC(=O)O)c1cccc([N+](=O)[O-])c1)N1C(=O)N[C@](C)(c2ccc(C(=N)N)cc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.50
ITGA2B P08514 2/20 0.50
NQO2 P16083 1/20 0.40
F7 P08709 5/20 0.39
F3 P13726 5/20 0.39
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
F10 P00742 1/20 0.34
CYP26A1 O43174 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983582 0.89 ITGB3 (0.53) ITGB3ITGA2BPRSS1MEN1KMT2A
Hydrochloric Acid SCHEMBL7986512 0.87 ITGB3 (0.56) ITGB3ITGA2BMEN1KMT2AF10
Hydrochloric Acid SCHEMBL8489120 0.87 ITGB3 (0.56) ITGB3ITGA2BMEN1KMT2AF10
Hydrochloric Acid SCHEMBL8488362 0.87 ITGB3 (0.56) ITGB3ITGA2BMEN1KMT2AF10
Hydrochloric Acid SCHEMBL7969557 0.87 ITGB3 (0.56) ITGB3ITGA2BMEN1KMT2AF10
SCHEMBL7500179 0.86 ITGB3 (0.35) ITGB3ITGA2BCRHBPCRHR2MEN1
SCHEMBL7983505 0.86 ITGB3 (0.52) ITGB3ITGA2BF7MEN1KMT2A
SCHEMBL7981888 0.84 ITGB3 (0.50) ITGB3ITGA2BMEN1KMT2A
SCHEMBL7981063 0.84 ITGB3 (0.51) ITGB3ITGA2BF7F3PRSS1
SCHEMBL8489046 0.83 ITGB3 (0.52) ITGB3ITGA2BNQO2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191282-B1 DERIVATIVES OF 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING IS USED AS ANTICARCINOGENIC AGENT AND ANTICOAGULANT HOECHST MARION ROUSSEL (DE) 2001-02-20 US disclosed
US-5981492-A ADMINISTERED TO THE PATIENT TO INHIBIT THROMBOCYTE AGGREGATION, THE METASTASIZATION OF CARCINOMA CELLS, THE BINDING OF OSTEOCLASTS TO THE BONE SURFACE, OR FOR THE TREATMENT OF THROMBOSES HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed